Atlas Trials

Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism

Clinical trial NCT02781844 · COMPLETED

Trial details

NCT number
NCT02781844
Sponsor
Shire
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypoparathyroidism
Start date
2017-04-03
Primary completion
2019-03-08
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.